慈善药物开发:了解其重要性,机制和未来前景
Marc Reichel1, Eva M Murauer2, Martin Steiner3
1University Witten/Herdecke, 58455 Witten, Germany.
Drug discovery today
|January 23, 2025
概括
慈善药物开发 (PDD) 解决了罕见疾病的未满足需求. 患者组织 (PO) 通过与制药公司合作,减少发展挑战和促进以患者为中心的疗法来推动创新.
科学领域:
- 药物开发 药物开发
- 制药创新 制药创新 制药创新
- 罕见疾病 罕见疾病
背景情况:
- 由于成本和时间障碍,传统的制药创新面临着解决罕见和服务不足的疾病的挑战.
- 利基治疗领域往往缺乏商业投资,在治疗选择中造成了重大差距.
- 患者组织 (PO) 拥有独特的专业知识,可以减轻这些发展挑战.
研究的目的:
- 突出慈善药物开发 (PDD) 在解决制药创新的差距方面的作用.
- 强调患者组织 (PO) 在克服药物开发障碍方面的关键贡献.
- 探索PDD如何促进以患者为中心的创新,并使药品组合多样化.
主要方法:
- 分析PDD模型及其对伙伴关系的依赖.
- 检查PO在研究,合作和临床试验方面的具体贡献.
- 审查PDD如何使制药公司进入商业上无利可图的治疗领域.
主要成果:
- PDD有效地弥合了罕见和服务不足的疾病的创新差距.
- 药品生产组织通过专业知识,早期研究支持和试验促进,显著减少药物开发挑战.
- 药品生产商和制药公司之间的有效伙伴关系确保患者的观点指导开发过程.
结论:
- 慈善药物开发 (PDD) 是一种可行的策略,可以促进以患者为中心的创新.
- 产业组织是PDD的重要合作伙伴,在传统模式忽视的领域推动了进步.
- PDD允许制药公司扩展到新的领域并使投资组合多样化,使罕见疾病患者受益.
相关概念视频
01:26Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
01:26Drug Administration and Therapy Phases: Overview
406
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
406
01:21Pharmacodynamics: Overview and Principles
947
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
947
01:28Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
01:24Principles of Drug Action
5.7K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.7K
01:11Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K